The Cuff That Could Arrest the Aging Process

Dr. Rene Cuadra, a resident who assists in the INFINITY trial, shows study participant Gerald Kehoe how to use a 24-hour blood pressure monitor. (Chris DeFrancesco/UConn Health Photo)
Dr. Rene Cuadra, a resident who assists in the INFINITY trial, shows study participant Gerald Kehoe how to use a 24-hour blood pressure monitor. (Chris DeFrancesco/UConn Health Photo)
Learn more or join the study:
1-860-679-2705

Could the aging process be slowed – or even stopped – by aggressively managing an older person’s hypertension, or high blood pressure?
Researchers at UConn Health are finding blood pressure to be a reliable predictor of the progression of what’s known as “white matter disease,” or small-vessel disease of the brain, which impacts the decline in cognitive function, mobility, and balance associated with aging.

But it goes beyond putting on a blood pressure cuff during the occasional visit to the doctor’s office.

“We’ve learned from prior research that there is an important relationship between out-of-office blood pressure – but not doctor’s office pressure – and the progression of blood vessel disease of the brain and its associated decline in function,” says Dr. William B. White, professor of medicine and chief of the Calhoun Cardiology Center Division of Hypertension and Clinical Pharmacology. “The program we’re doing now is actually evaluating interventions using 24-hour monitoring to guide the therapy that we hope will prevent the functional loss.”

Dr. William White is running a clinical trial studying the connection between blood pressure management and aging.
Dr. William White is running a clinical trial studying the connection between blood pressure management and aging.

Along the way, White, the immediate past president of the American Society of Hypertension, has made some incidental observations.

“We’ve found in a number of cases that the hypertensive patients joining this study were actually overmedicated,” White says. “We were able to bring their blood pressure under control by reducing their medications. The around-the-clock blood pressure monitoring provides us the crucial data that enables us to this. More isn’t always better.”

Such was the case for Gerald Kehoe, who joined the study two and a half years ago. He recalls he was having great difficulty controlling his hypertension.

“I came here because of Dr. White’s reputation, and I believed he could stabilize my blood pressure,” Kehoe says. “This allows me to take my blood pressure over 24 hours and give Dr. White an idea of how my blood pressure changes during different times and events. That’s the way we learned how erratic our blood pressure is. Without that I don’t think they could regulate it fully.”

Kehoe says White reduced his medications and was able to stabilize his blood pressure.

Kehoe also got his wife to join the study. Fran Kehoe’s improvement was less drastic than her husband’s – she had less room for improvement.
“The people here are really nice, and I joke with them, ‘Oh, you like him better,’” Fran Kehoe says. “But you’re doing this for other people who are coming along later. If they can find out what caused the problem, they can save somebody else.”

Radio Health Minute
Listen to Dr. White explain the goals of the INFINITY Trial

Fran Kehoe says she’s living proof of the difference clinical trials can make, noting that she, as a cancer survivor, is the beneficiary of someone’s past participation.

INFINITY Trial participant Fran Kehoe is timed and observed walking up and down stairs. (Chris DeFrancesco/UConn Health Photo)
INFINITY Trial participant Fran Kehoe is timed and observed walking up and down stairs. (Chris DeFrancesco/UConn Health Photo)

Gerald Kehoe says the study also has short-term benefits for the participants.

“I feel wonderful,” he says. “I really appreciate what the study has done for me, and I hope it will do the same for other people.”
Study participants receive blood pressure care and treatment, including medications, over a three-year period, during which they undergo a series of tests to measure mobility, cognitive function, and white matter hyperintensities, the signs of small vessel brain damage. Participants periodically wear an ambulatory blood pressure monitor for 24-hour duration.

The researchers, led by White and Dr. Leslie Wolfson, professor of neurology, are in the home stretch of recruiting study participants for what’s known as “The INFINITY Trial,” a multi-year, $3.4 million study funded by the National Institute on Aging, a division of the National Institutes of Health.

Those interested in joining or learning more about INFINITY, which stands for “Intensive Versus Standard Ambulatory Blood Pressure Levels to Prevent Functional Decline in the Elderly,” should call 860-679-2705. Study participants must be at least 75 years old, have a history of hypertension, and cannot have a history of clinical stroke or major neurologic disability. The doctors and project man
agers can determine potential eligibility with a simple phone interview.

Follow UConn Health on Facebook, Twitter, YouTube, and SoundCloud.